Panacea Biotec to manufacture up to 25 mn doses of Sputnik V vaccine
Shares of Panacea Biotec ended at Rs 356.40 per scrip on BSE, up 2.77 per cent from its previous close.05-08-2021
05-08-2021
Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), we are pleased to inform you that the Company has, on August 3, 2021, entered into a Licensing and Manufacturing Agreement with Human Vaccine Limited Liability Company, a subsidiary of Russian Direct Investment Fund, Russia, GENERIUM Joint Stock Company and Dr. Reddy's Laboratories Limited. The detailed disclosure as required under Regulation 30 of SEBI LODR Regulations in respect of the above mentioned matter is annexed herewith.05-08-2021
Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Investor Presentation
In continuation to our letter dated July 28, 2021 and in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the revised Investor Presentation uploaded on the website of the Company at the link: https://www.panaceabiotec.com/comorate-presentation. The Company will now use this presentation for meetings with analysts / institutional investors. This is for your kind information and record please.02-08-2021
Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Investor Presentation
In compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation uploaded on the website of the Company at the link: https://www.panaceabiotec.com/corporate-presentation. The Company will use this presentation for meetings with analysts / institutional investors. This is for your kind information and record please.28-07-2021
PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated July 23, 2021 for approving the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company for the Quarter ended June 30, 2021 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the Extract of Statement of aforesaid Unaudited Financial Results published in the following newspapers on July 24, 2021:- Business Standard (English); Desh Sewak (Punjabi) This is for your kind information and record please26-07-2021
PANACEA BIOTEC LTD. - 531349 - Intimation Of Book Closure For The 37Th Annual General Meeting
We wish to you that the Register of Members and Share Transfer Books will remain closed from Saturday, September 18, 2021 to Saturday, September 25, 2021 (both days inclusive) for the purpose of Annual General Meeting.24-07-2021
PANACEA BIOTEC LTD. - 531349 - Fixes Book Closure for AGM
Panacea Biotec Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 18, 2021 to September 25, 2021 (both days inclusive) for the purpose of 37th Annual General Meeting (AGM) of the Company to be held on September 25, 2021.24-07-2021
PANACEA BIOTEC LTD. - 531349 - Outcome of Board Meeting (AGM on Sept 25, 2021)
Panacea Biotec Ltd has informed BSE regarding Outcome of Board Meeting held on July 23, 2021.23-07-2021
PANACEA BIOTEC LTD. - 531349 - Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2021
In continuation to our letter dated July 15, 2021 and pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. July 23, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on July 23, 2021. The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 4:00 P.M. We request you to kindly bring the above information to the notice of your members.23-07-2021
PANACEA BIOTEC LTD. - 531349 - Outcome Of Board Meeting
We would like to inform you that the Board of Directors of the Company has, at its meeting held 23.07.2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on July 23, 2021. We wish to further inform you that the Board of Directors has also decided that: i) the 37th Annual General Meeting of the Company will be held on Saturday, September 25, 2021 at 11:30 A.M. through Video Conferencing / Other Audio-Visual Means; and ii) the Register of Members and Share Transfer Books will remain closed from Saturday, September 18, 2021 to Saturday, September 25, 2021 (both days inclusive) for the purpose of Annual General Meeting. The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 4:00 P.M23-07-2021